Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
176 USD | +2.06% | +6.36% | -2.10% |
May. 02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
May. 01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.10% | 9.84B | |
-4.98% | 182B | |
+2.84% | 112B | |
-2.68% | 68.58B | |
+4.53% | 51.58B | |
+8.00% | 44.24B | |
+9.45% | 43.65B | |
+25.30% | 32.46B | |
+20.94% | 25.99B | |
-0.17% | 25.61B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Transcript : Repligen Corporation, Q2 2022 Earnings Call, Aug 02, 2022